(Adnkronos) – When discussing thrombosis in women who are pregnant, postpartum, or taking birth control pills, "it's important not to create alarmism. The risk from taking hormonal drugs, especially those containing estrogen and progestins, is modest, and this must be emphasized." This was stated by Elvira Grandone, vice president and president-elect of Siset, attending today's 29th National Congress of the Italian Society for the Study of Hemostasis and Thrombosis.
This event represents a great opportunity for all Italian researchers to meet and present the latest research results in the field.
“The use of estrogen-progestins occurs both for contraceptive purposes and for therapeutic purposes for numerous conditions that can negatively affect female fertility and for which hormone therapy is often a necessary treatment,” the expert continues. “The risk is absolutely low in absolute terms, and all international scientific societies are aligned on this point.
The effort we must make is to identify, among the many women to whom we prescribe these products, those who deserve special attention. Today, we have so many drugs available, and for this reason, treatment must be personalized, increasingly tailored."
The need for greater attention to women's health also concerns the recognition of thromboembolic and haemorrhagic diseases.
"These conditions," Grandone explains, "are often poorly understood, not only because some are rare and therefore less discussed than diseases with a higher incidence in the general population. We too," clinicians, "have a reduced awareness, especially regarding certain segments of the population that are less present and less represented in the scientific literature. I'm thinking, for example, of women who experience menstrual cycle problems or bleeding at other stages of life, even after their reproductive years have ended. These symptoms are generally attributed to problems with the reproductive organs and not to possible coagulation disorders," he concludes.
News
webinfo@adnkronos.com (Web Info)
